David Windley
Stock Analyst at Jefferies
(4.49)
# 793
Out of 5,182 analysts
209
Total ratings
66.39%
Success rate
13.9%
Average return
Main Sectors:
Stocks Rated by David Windley
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| UNH UnitedHealth Group | Maintains: Buy | $340 → $373 | $354.92 | +5.09% | 29 | Apr 20, 2026 | |
| ELV Elevance Health | Maintains: Buy | $395 → $391 | $344.76 | +13.41% | 2 | Apr 20, 2026 | |
| CI The Cigna Group | Maintains: Buy | $333 → $330 | $275.64 | +19.72% | 18 | Apr 20, 2026 | |
| CNC Centene | Maintains: Hold | $37 → $39 | $41.82 | -6.74% | 29 | Apr 20, 2026 | |
| OSCR Oscar Health | Upgrades: Hold | $10 → $16 | $16.81 | -4.82% | 2 | Apr 20, 2026 | |
| ICLR ICON Public Limited Company | Upgrades: Buy | $175 → $135 | $102.17 | +32.13% | 16 | Feb 23, 2026 | |
| MEDP Medpace Holdings | Upgrades: Buy | $560 | $410.54 | +36.41% | 7 | Feb 13, 2026 | |
| HUM Humana | Maintains: Buy | $310 → $235 | $215.23 | +9.19% | 20 | Feb 12, 2026 | |
| IQV IQVIA Holdings | Maintains: Buy | $270 → $255 | $162.28 | +57.14% | 6 | Feb 6, 2026 | |
| DEO Diageo | Downgrades: Neutral | n/a | $79.29 | - | 1 | Dec 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $7 → $9.5 | $9.80 | -3.06% | 3 | Sep 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $142 → $195 | $169.80 | +14.84% | 20 | Sep 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $263 | $221.80 | +18.58% | 1 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $2.75 | $0.91 | +202.26% | 1 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $354 → $297 | $175.94 | +68.81% | 23 | Jul 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $12 → $3.75 | $0.29 | +1,190.43% | 4 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $365 → $375 | $482.22 | -22.23% | 1 | Apr 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $15 → $16 | $15.58 | -0.51% | 3 | Mar 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $225 → $270 | $161.13 | +67.57% | 2 | Mar 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $14 → $16 | $6.32 | +145.25% | 3 | Mar 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $323 → $536 | $306.16 | +75.07% | 10 | Feb 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $39 → $29 | $16.18 | +79.23% | 2 | Nov 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $264 → $248 | $5.75 | +4,213.04% | 1 | Feb 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $0.91 | - | 5 | Oct 9, 2017 |
UnitedHealth Group
Apr 20, 2026
Maintains: Buy
Price Target: $340 → $373
Current: $354.92
Upside: +5.09%
Elevance Health
Apr 20, 2026
Maintains: Buy
Price Target: $395 → $391
Current: $344.76
Upside: +13.41%
The Cigna Group
Apr 20, 2026
Maintains: Buy
Price Target: $333 → $330
Current: $275.64
Upside: +19.72%
Centene
Apr 20, 2026
Maintains: Hold
Price Target: $37 → $39
Current: $41.82
Upside: -6.74%
Oscar Health
Apr 20, 2026
Upgrades: Hold
Price Target: $10 → $16
Current: $16.81
Upside: -4.82%
ICON Public Limited Company
Feb 23, 2026
Upgrades: Buy
Price Target: $175 → $135
Current: $102.17
Upside: +32.13%
Medpace Holdings
Feb 13, 2026
Upgrades: Buy
Price Target: $560
Current: $410.54
Upside: +36.41%
Humana
Feb 12, 2026
Maintains: Buy
Price Target: $310 → $235
Current: $215.23
Upside: +9.19%
IQVIA Holdings
Feb 6, 2026
Maintains: Buy
Price Target: $270 → $255
Current: $162.28
Upside: +57.14%
Diageo
Dec 3, 2025
Downgrades: Neutral
Price Target: n/a
Current: $79.29
Upside: -
Sep 9, 2025
Maintains: Hold
Price Target: $7 → $9.5
Current: $9.80
Upside: -3.06%
Sep 9, 2025
Upgrades: Buy
Price Target: $142 → $195
Current: $169.80
Upside: +14.84%
May 29, 2025
Initiates: Hold
Price Target: $263
Current: $221.80
Upside: +18.58%
May 21, 2025
Initiates: Hold
Price Target: $2.75
Current: $0.91
Upside: +202.26%
Jul 24, 2024
Maintains: Hold
Price Target: $354 → $297
Current: $175.94
Upside: +68.81%
May 14, 2024
Downgrades: Hold
Price Target: $12 → $3.75
Current: $0.29
Upside: +1,190.43%
Apr 19, 2024
Maintains: Hold
Price Target: $365 → $375
Current: $482.22
Upside: -22.23%
Mar 25, 2024
Upgrades: Buy
Price Target: $15 → $16
Current: $15.58
Upside: -0.51%
Mar 4, 2024
Maintains: Buy
Price Target: $225 → $270
Current: $161.13
Upside: +67.57%
Mar 1, 2024
Maintains: Hold
Price Target: $14 → $16
Current: $6.32
Upside: +145.25%
Feb 7, 2024
Upgrades: Buy
Price Target: $323 → $536
Current: $306.16
Upside: +75.07%
Nov 1, 2023
Downgrades: Hold
Price Target: $39 → $29
Current: $16.18
Upside: +79.23%
Feb 25, 2021
Maintains: Hold
Price Target: $264 → $248
Current: $5.75
Upside: +4,213.04%
Oct 9, 2017
Upgrades: Buy
Price Target: n/a
Current: $0.91
Upside: -